Krystal Biotech, Inc. (KRYS)
272.74
+5.10
(+1.91%)
USD |
NASDAQ |
Feb 06, 16:00
278.19
+5.45
(+2.00%)
After-Hours: 07:24
Krystal Biotech Total Liabilities (Quarterly) : 102.22M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 638.39M |
| DexCom, Inc. | 4.774B |
| Alkermes Plc | 596.08M |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.240B |
| Shareholders Equity (Quarterly) | 1.138B |
| Debt to Equity Ratio | 0.0084 |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | -0.01% |